Readystate Asset Management »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Readystate Asset Management

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Readystate Asset Management from 13F filings

Historical chart of Readystate Asset Management investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Readystate Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Readystate Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $7.9M 8.5M 0.93
2023-09-30 $5.2M 5.5M 0.94

More positions owned by Readystate Asset Management

Ishares Tr Russell 2000 Etf Call Option (IWM)
Pfizer Call Option (PFE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Alnylam Pharmaceuticals Note 1.000% 9/1 (Principal)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Wolfspeed Note 1.875%12/0 (Principal)
Select Sector Spdr Tr Financial (XLF)
Lantheus Hldgs Note 2.625%12/1 (Principal)
Sarepta Therapeutics Note 1.250% 9/1 (Principal)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Alphatec Hldgs Note 0.750% 8/0 (Principal)
Veradigm Note 0.875% 1/0 (Principal)
Builders FirstSource Put Option (BLDR)
Peabody Energy Corp Note 3.250% 3/0 (Principal)

View all positions for Readystate Asset Management

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&g Investment Management
M&G
Calamos Advisors
Wolverine Asset Management
MacKay Shields
Citadel Advisors
Polar Securities
Millennium Management
Bank Of Montreal
Kohlberg Kravis Roberts & Co
D. E. Shaw & Co
Absolute Investment Advisers
Leucadia National Corporation
SSI Investment Management
CSS

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1